The COVID-19 pandemic thrust medical research into the global spotlight. It bridged established disconnects between scientists and the public, between science and industry, and within the scientific community itself. It demonstrated the power of researchers working collaboratively towards a common goal. And yet, the pandemic also fostered unprecedented levels of scientific competition.
Aishwarya Vedula discusses the development of a novel machine learning approach that could revolutionise phenotypic drug discovery.
Maisie Lambert explores how gender bias and biological differences contribute to the ADHD underdiagnosis in women and ensuing consequences.
Madison Williams explores the increasing research around the tiny microbe inhabitants of the human gut and their role in health and disease.
Maisie Saunders explores how quantum mechanics may underpin key biological processes, from photosynthesis to bird navigation and smell.
Jessica Sutton reports on Weald to Waves, a regenerative farming and conservation initiative creating a 100-mile wildlife corridor from the High Weald to the Sussex coast, aiming to reconnect fragmented habitats while supporting farmers, food production, and biodiversity recovery.
Eleanor Shuttleworth reports on an unexpected discovery that may offer a new way to tackle antibiotic resistance.
Hani Moussa traces how the transformer architecture revolutionised modern AI and its impact on industry, infrastructure, and computing.
Matt Donnelly examines the dramatic rise in autism diagnoses and explains why better recognition is behind the increased prevalence.
This article has been externally contributed, and the information contained within it has not been verified by our team The synthetic peptide AOD-9604 corresponds to the C-terminal segment (amino acids 177-191) of growth hormone (hGH), with an additional N-terminal tyrosine residue. It was originally designed to isolate the lipolytic (fat-metabolizing) domain of hGH while avoiding…
